Apolipoprotein E4 exhibits intermediates with domain interaction
Abstract
ApoE4(C112R) is the strongest risk factor for Alzheimer's disease, while apoE3(C112) is considered normal. The C112R substitution is believed to alter the interactions between the N-terminal (NTD) and the C-terminal domain (CTD) leading to major functional differences. Here we investigate how the molecular property of the residue at position 112 affects domain interaction using an array of C112X substitutions with arginine, alanine, threonine, valine, leucine and isoleucine as 'X'. We attempt to determine the free energy of domain interaction (∆G INT) from stabilities of the NTD (∆G NTD) and CTD (∆G CTD) in the full-length apoE, and the stabilities of fragments of the NTD (∆G NTF) and CTD (∆G CTF), using the relationship, ∆G INT = ∆G NTD + ∆G CTD - ∆G NTF - ∆G CTF. We find that although ∆G NTD is strongly dependent on the C112X substitutions, ∆G NTD - ∆G NTF is small. Furthermore, ∆G CTD remains nearly the same as ∆G CTF. Therefore, ∆G INT is estimated to be small and similar for the apoE isoforms. However, stability of domain interaction monitored by urea dependent changes in interdomain Forster Resonance Energy Transfer (FRET) is found to be strongly dependent on C112X substitutions. ApoE4 exhibits the highest mid-point of denaturation of interdomain FRET. To resolve the apparently contradictory observations, we hypothesize that higher interdomain FRET in apoE4 in urea may involve 'intermediate' states. Enhanced fluorescence of bis-ANS and susceptibility to proteolytic cleavage support that apoE4, specifically, the NTD of apoE4 harbor 'intermediates' in both native and mildly denaturing conditions. The intermediates could hold key to the pathological functions of apoE4.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The arginine at position 112 in ApoE4 is predicted to promote an interaction between the N- and C-terminal domains (domain interaction) that is absent in ApoE3 and ApoE2.
“The arginine at position 112 in ApoE4 is predicted to promote an interaction between the N-and C-terminal domains (domain interaction) that is absent in ApoE3 and ApoE2 23,26,27 .”
From Utilizing a cell culture based novel cellular thermal shift assay to understand the isoform-dependent thermal stability of ApoE variants (2026) · cites this paper as [27]
The first structural determination of the N-terminal domain of apoE3, reported in 1991, indicated that it is a unique four-α-helix bundle.
“The first structural determination of the N-terminal domain of apoE3, reported in 1991, indicated that it is a unique four-α-helix bundle (Fig.2)9, 10).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [10]
Cites
Three-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., & Agard, D. A. (1991) · Science · doi:10.1126/science.2063194 · Cited by 678 · see citing works
Apolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583 · see citing works
Wang, C., Najm, R., Xu, Q., Jeong, D.-E., Walker, D., Balestra, M. E., Yoon, S. Y., Yuan, H., Li, G., Miller, Z. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0004-z · Cited by 428 · see citing works
Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C. S., & Lindgren, F. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68779-4 · Cited by 229 · see citing works
Apolipoprotein E4 Forms a Molten Globule
Morrow, J. A., Hatters, D. M., Lu, B., Höchtl, P., Oberg, K. A., Rupp, B., & Weisgraber, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204898200 · Cited by 204 · see citing works
A Monomeric, Biologically Active, Full-Length Human Apolipoprotein E
Zhang, Y., Vasudevan, S., Sojitrawala, R., Zhao, W., Cui, C., Xu, C., Fan, D., Newhouse, Y., Balestra, R., Jerome, W. G., et al. (2007) · Biochemistry · doi:10.1021/bi700672v · Cited by 79 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features
Matsunaga, A., & Saito, T. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65393 · Cited by 14 · see citing works
Georgiadou, D., & Chroni, A. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149644 · Cited by 2 · see citing works
Jackson, R. J., Dierksmeier, S., Nishtar, M., Meltzer, J., Balduin, F., Beaumont, B., Fan, Z., Sergienko, E., Olson, S., Jackson, M. R., et al. (2026) · doi:10.64898/2026.06.09.730809
- Authors
- Dolai, S., Cherakara, S., & Garai, K.
- Affiliations
- Tata Institute of Fundamental Research (IN)
- Corresponding author
- Garai, Kanchan
- Venue
- Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 1868
- Issue
- 12
- Pages
- 140535
- ISSN
- 1570-9639 (ISSN-L)
- OpenAlex
- W3082513061
- Cited by
- 13
- References
- 6
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 3 · 2022: 2
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board
- Department of Atomic Energy, Government of India
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- APOE ε4, apolipoprotein E isoforms, N-terminal domain, C-terminal domain, domain interactions, free energy of interaction, protein stability, urea denaturation, protein intermediates, Alzheimer's disease risk, proteolytic cleavage
- MeSH terms
- Humans, Kinetics, Models, Molecular, Mutation, Protein Binding, Structure-Activity Relationship, Protein Isoforms, Apolipoprotein E3, Apolipoprotein E4, Protein Interaction Domains and Motifs, Protein Stability, Protein Unfolding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review